Clinical trial
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study - Intervention Pilot Study
NCT05191225 is registered in ClinicalTrials.gov with Laida Cuevas Palomares as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study - Intervention Pilot Study
- Lead sponsor
- Laida Cuevas Palomares
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 28, 2021
- Completion date
- December 31, 2022
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-hodgkin's lymphoma